Ritedose receives FDA approval for Tobramycin Tobramycin expands nation's largest nebulized drug portfolio. - Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the ...

The United States nebulizer market is set to grow from US$ 466.55 million in 2024 to US$ 730.62 million by 2033, with a CAGR of 5.11%. This growth is driven by the rising prevalence of respiratory ...

The latest announcement is out from BiomX ( (PHGE) ).

BiomX believes that it has fully addressed the FDA’s queries related to the third-party nebulizer used to deliver BX004, which are narrow in scope; an additional FDA request for limited technical ...

Detainee claims ICE used "the WRAP" to restrain him for over 16 hours. AP found 12 deaths tied to the device in U.S. law enforcement. Cardiologist: 9 American foods you 'couldn't pay me to eat'—after ...

Oct 8 (Reuters) - The U.S. Food and Drug Administration on Wednesday cleared Regeneron Pharmaceuticals’ (REGN.O), opens new tab immunotherapy, Libtayo, as an add-on treatment for skin cancer patients ...

State funding is earmarked for substance use disorder treatment programming at Danville's Adult Detention Center. Photo by Grace Mamon. The Danville City Council will consider approving state funding ...

Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin. Serenity Inns, a Milwaukee-based nonprofit that provides ...

Illustration courtesy of Vivian Chang This 3-part series looks at the current evidence for the treatment of SUDs. Part 2 reviews the use of GLP-1 receptor agonists and alcohol use disorder. Alcohol ...

Only a handful of people charged with low-level drug offenses in Seattle received treatment since the city passed a law in 2023 aimed at combating public drug use, according to a report released ...